AMY AKINS: Open Payments
NPI 1003548769 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 10 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $203 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $54 |
| Novo Nordisk Inc | 2 | $45 |
| Antares Pharma, Inc. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Veozah, XYOSTED, Ozempic, Wegovy, FARXIGA, MOUNJARO, SHINGRIX.
Industry payments across TX — which companies pay providers there.
